March 20, 2020
The FDA announced today a new policy that permits expanded use of connected, non-invasive remote vital sign monitors until the end of the COVID-19 public health emergency.
The agency is relaxing its prior guidance so that healthcare teams can monitor their patients outside of the hospital with certain devices that were previously cleared by the FDA, thereby freeing up space for the high volume...
January 28, 2020
San Francisco-based EHR developer Practice Fusion has agreed to pay $145 million alongside an admission that it “solicited and received kickbacks from a major opioid company” in exchange for clinical decision support (CDS) alerts promoting unnecessary prescription opioids, according to a release from the US Department of Justice.
In a settlement announced yesterday (and hinted at in an earnings...
November 19, 2019
Ada Health is expanding its services in East Africa with a new Swahili language version of its artificial intelligence assessment app.
The tool is pitched as a way for clinicians and patients to get more information about potential symptom causes as well as localized action steps about what to do next.
“The Swahili version of the Ada app can be accessed via smartphone, and offers support to...
November 18, 2019
This morning Biofourmis, maker of an artificial intelligence-enabled monitoring and decision support platform, announced its plans to acquire Zürich, Switzerland-based wearable biosensor company Biovotion. The terms of the deal are not disclosed; however, we do know the deal is made up of a combination of cash and equity.
The acquisition will include Biovotion’s clinical grade-wearable...
October 24, 2019
Healthcare AI company Viz.ai announced that it landed a whopping $50 million in Series B funding this morning. This latest infusion of cash was led by Greenoaks, with participation from Threshold Ventures, CRV, GV and Kleiner Perkins.
The new funding comes a little over a year after the Israeli company raised $21 million from Kleiner Perkins and GV.
WHAT THEY DO
Viz.ai focuses on using AI to...
September 26, 2019
This morning the FDA released two guidance documents relating to the regulation of various digital health software devices.
The first is a draft guidance outlining categories of clinical decision support (CDS) products that would or would not require direct regulatory oversight from the agency. This is an update to a CDS draft guidance released in 2017, with the noteworthy addition of a risk-...
September 26, 2019
Mednition, makers of machine learning-powered solutions for healthcare, announced Wednesday that the company has raised $10 million in a Series A round of funding led by healthcare private equity firm Concord Health Partners. Concord tapped its American Hospital Association Innovation Fund for the financing.
WHAT THEY DO
Burlingame, California-based Mednition was founded in 2014 to help...
February 14, 2019
New research published in the BMJ this week has shown that access to online decision support and feedback for UK GPs led to a decrease in the number of unnecessary antibiotic prescriptions for respiratory illness by 12 percent.
A team from the School of Population Health and Environmental Sciences at King’s College London carried out the year-long trial, funded by National Institute for Health...
January 16, 2019
This morning healthcare data platform Innovaccer announced that it has raised an additional $10 million in funding, boosting its Series B funding round up to $35 million.
The additional funding was led by Microsoft’s venture fund M12, with participation from Westbridge Capital and Lightspeed. In May the company announced the first $25 million of its Series B funding, which was led by Westbridge...
October 10, 2018
NASA is turning its attention to digital clinical support tools to treat astronauts that get sick or injured while in outer space. This morning the news broke that NASA will be piloting Wolters Kluwer’s UpToDate tool, which gives users evidence-based clinical decision support resources, on the International Space Station. According to the company, this marks the first time a clinical decision...